Evidence map›Paper›PMID 26853625›Full record

ArticleCell chemical biology2016

Systematic Survey of Serine Hydrolase Activity in Mycobacterium tuberculosis Defines Changes Associated with Persistence.

Corrie Ortega, Lindsey N Anderson, Andrew Frando, Natalie C Sadler, Robert W Brown, Richard D Smith, Aaron T Wright, Christoph Grundner

Open access · bronzeAbstract read
In one paragraph

Article in Cell chemical biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
7.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 86 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Roles of Lipolytic enzymes inFrontiers in microbiology · 2024
    Review
  9. Article
  10. Article
  11. Target Identification in Anti-Tuberculosis Drug Discovery.International journal of molecular sciences · 2023
    Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Corrie OrtegaCenter for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, WA 98109, USA.
Lindsey N AndersonBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Andrew FrandoCenter for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA.
Natalie C SadlerBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Robert W BrownCenter for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, WA 98109, USA.
Richard D SmithBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA.
Aaron T WrightBiological Sciences Division, Pacific Northwest National Laboratory, Richland, WA 99352, USA. Electronic address: aaron.wright@pnnl.gov.
Christoph GrundnerCenter for Infectious Disease Research (formerly Seattle Biomedical Research Institute), Seattle, WA 98109, USA; Department of Global Health, University of Washington, Seattle, WA 98195, USA. Electronic address: christoph.grundner@cidresearch.org.
Center for Infectious Disease Research · USPacific Northwest National Laboratory · US

Funding

Equipment Supplement Request for a Research Resource for Ultra-sensitive High Throughput ProteomicsP41GM103493 · NIGMS · BATTELLE PACIFIC NORTHWEST LABORATORIES · PI SMITH, RICHARD D · 2012 to 2022
$22.6M
NIAID NIH HHS HHSN272201200025CNIGMS NIH HHS P41 GM103493PHS HHS HHSN272201200025C
6 · The paper itself

Abstract

The transition from replication to non-replication underlies much of Mycobacterium tuberculosis (Mtb) pathogenesis, as non- or slowly replicating Mtb are responsible for persistence and poor treatment outcomes. Therapeutic targeting of non-replicating populations is a priority for tuberculosis treatment, but few drug targets in non-replicating Mtb are currently known. Here, we directly measured the activity of the highly diverse and druggable serine hydrolases (SHs) during active replication and non-replication using activity-based proteomics. We predict SH activity for 78 proteins, including 27 proteins with unknown function, and identify 37 SHs that remain active in the absence of replication, providing a set of candidate persistence targets. Non-replication was associated with major shifts in SH activity. These activity changes were largely independent of SH abundance, indicating extensive post-translational regulation of SHs. By probing a large cross-section of druggable Mtb enzyme space during replication and non-replication, we identify new SHs and suggest new persistence targets.

Indexed as

Chromatography, LiquidDrug Resistance, BacterialEnzyme ActivationHydrolasesMass SpectrometryMycobacterium tuberculosisSerineHydrolasesSerine

Identifiers

PMID26853625
PMCPMC4803444
OpenAlexW2281147173

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.